You are currently viewing a new version of our website. To view the old version click .
Molecules
  • Short Note
  • Open Access

25 March 2001

N-(2-Ethylmorpholino)-3-bis-keto(1-naphthyl)oxindole

Department of Medicinal Chemistry, Victorian College of Pharmacy (Monash University), 381 Royal Parade Parkville, Victoria 3052, Australia
This article belongs to the Section Molbank Section of Molecules, 1997-2001
As part of a research programme targeting novel indole-like molecules as potential cannabinoid agonists [1,2,3,4] we synthesised N-(2-ethylmorpholino)-3-bis-keto(1-naphthyl)oxindole.
Molecules 06 m196 i001
N-(ethylmorpholine) oxindole (409.0 mg, 1.66 mmol) was dissolved in anhydrous THF (25.0 mL) and the reaction mixture was cooled to -78 °C then HMPA (868.0 mL, 4.99 mmol) was added followed by KHMDS (3.66 mL, 1.83 mmol) being added dropwise. The solution was stirred for 30 minutes at -22 °C then cooled to -78 °C after which 1-naphthyl chloride (475.0 mg, 2.49 mmol) was added. The reaction was allowed to stir up to room temperature overnight. The solvent was evaporated under reduced pressure and water was added and the aqueous phase was extracted with ethyl acetate, dried over magnesium sulphate, filtered, and evaporated under reduced pressure to afford (552.5 mg, 60.0 %) of the undesired N-(ethylmorpholine)-3-bis keto(-1-naphthyl) oxindole as a yellow powder.
M.p. 80-85 °C.
MS: 555 (M+1)+..
IR: 3080, 1800, 1600, 1420, 1300, 1110, 1100, 950, 700.
1H NMR (300 MHz, CDCl3): 2.55 (m, 4H, 2 x CH2), 2.66 (t, J = 6.9 Hz, 2H, CH2), 3.71 (m, 4H, 2 x CH2) 3.93 (t, J = 6.9 Hz, 2H, CH2), 6.07 (m, 1H, ArH), 6.59 (dd, J = 0.9 Hz, J = 7.5 Hz, 1H, ArH), 6.86 (d, J = 7.8 Hz, 1H, ArH), 7.15 (m, 1H, ArH), 7.55 (m, 5H, 5 x ArH), 7.85-8.13 (m, 6H, 6 x ArH), 8.28 (m, 1H, ArH), 8.53 (m, 1H, ArH), 8.95 (m, 1H, ArH).
Anal. calcd. for C36H30N2O4 C 77.96, 5.45: Found C 77.65, H 5.50.

Supplementary materials

Supplementary File 1Supplementary File 2

References

  1. Ward, S. J.; Mastriani, D.; Casiano, F.; Arnold, R. J. Pharmacol. Exp. 1990, 255, 1230–1239.
  2. Bell, M. R.; D'Ambra, T. E.; Kumar, V.; Eissenstat, M. A.; Herrmann, J. L.; Wetzel, J. R.; Rosi, D.; Philion, R. E.; Daum, S. J.; Hlasta, D. J.; Kullnig, R. K.; Ackerman, J. H.; Haubrich, D. R.; Luttinger, D. A.; Baizman, E. R.; Miller, M. S.; Ward, S. J. J. Med. Chem. 1991, 34, 1099–1110. [CrossRef]
  3. Ward, S. J.; Miller, M. S.; Luttinger, D. A.; Eissenstat, M. A.; Bell, M. R. Neurosci. Abstr. 1988, 14, 324.
  4. D'Ambra, T. E.; Estep, K. G.; Bell, M. R.; Eissenstat, M. A.; Josef, K. A.; Ward, S. J.; Haycock, D. A.; Baizman, E. R.; Casiano, F. M.; Belgin, N. C.; Chippari, S. M.; Grego, J. D.; Kullnig, R. K.; Daley, G. T. J. Med. Chem. 1992, 35, 124–135. [CrossRef]
  • Sample availability: available from the authors and MDPI.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.